G01N 2333/5415
Leukaemia inhibitory factor [lif]
Official title: Leukaemia inhibitory factor [LIF]
G01N2333/5415 (Leukaemia inhibitory factor [lif]) appears on 5 US grants and 11 published applications in this corpus.
Search patents in G01N- Granted patents
- 5
- Published applications
- 11
- Assignees
- 17
- Inventors
- 29
- Latest grant
- 6 Jan 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2013 | 0 | 1 |
| 2014 | 0 | 1 |
| 2015 | 2 | 3 |
| 2016 | 0 | 2 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 1 | 1 |
| 2020 | 0 | 0 |
| 2021 | 1 | 2 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 0 |
| 2026 | 1 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Method for measuring systemic chronic inflammaging6 Jan 2026US 12,517,135 B2Edifice Health, Inc.
- Antibody recognizing human leukemia inhibitory factor (LIF) and use of anti-LIF antibodies in the treatment of diseases associated with unwanted cell proliferation6 Apr 2021US 10,968,273 B2Fundacio Privada Institut D'Investigació OncolòGica Vall D'Hebron (Vhio)
- Gene and protein expression properties of adherent stromal cells cultured in 3D16 Jul 2019US 10,351,910 B2Pluristem Ltd.
- Potentiation of nanopharyngeal cancer radiotherapy by inhibitors of leukemia inhibitory factor24 Nov 2015US 9,194,872 B2Chang Gung University
- Antibody recognizing human leukemia inhibitory factor (LIF)6 Jan 2015US 8,926,956 B2Fundacio Privada Institucio Catalana De Recerca I Estudis Avancats (Icrea)
- Metal nanoparticle, and plasmonic biosensor comprising the same9 Apr 2026US 2026/0098867 A1Korea University Research and Business Foundation
- Methods of quantifying lif and uses thereof24 Jun 2021US 2021/0190798 A1Fundació Privada Institució Catalana de Recerca | Estudis Avançats
- Method for measuring systemic chronic inflammaging15 Apr 2021US 2021/0109109 A1Edifice Health, Inc.
- Antibody recognizing human leukemia inhibitory factor (lif) and use of anti-lif antibodies in the treatment of diseases associated with unwanted cell proliferation25 Apr 2019US 2019/0119373 A1Fundacio Privada Institucio Catalana De Recerca I Estudis Avancats (Icrea)
- Methods and Compositions for Targeting Tumor Microenvironment and for preventing Metastasis18 Aug 2016US 2016/0237158 A1Centre National de la Recherche Scientifique (CNRS)
Most cited
By later US patents
- Potentiation of nanopharyngeal cancer radiotherapy by inhibitors of leukemia inhibitory factor6US 9,194,872 B2Chang Gung University · 2015
- Antibody recognizing human leukemia inhibitory factor (LIF)4US 8,926,956 B2Fundacio Privada Institucio Catalana De Recerca I Estudis Avancats (Icrea) · 2015
- Antibody recognizing human leukemia inhibitory factor (LIF) and use of anti-LIF antibodies in the treatment of diseases associated with unwanted cell proliferation2US 10,968,273 B2Fundacio Privada Institut D'Investigació OncolòGica Vall D'Hebron (Vhio) · 2021